Schmidt, S. ; Stautner, C. ; Vu, D.T.* ; Heinz, A.* ; Regensburger, M.* ; Karayel, O.* ; Trümbach, D. ; Artati, A. ; Kaltenhäuser, S.* ; Nassef, M.Z.* ; Hembach, S. ; Steinert, L. ; Winner, B.* ; Jürgen, W.* ; Jastroch, M.* ; Luecken, M. ; Theis, F.J. ; Westmeyer, G.G. ; Adamski, J. ; Mann, M.* ; Hiller, K.* ; Giesert, F. ; Vogt Weisenhorn, D.M. ; Wurst, W.
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson's disease.
Nat. Commun. 14:7674 (2023)
Sporadic Parkinson's Disease (sPD) is a progressive neurodegenerative disorder caused by multiple genetic and environmental factors. Mitochondrial dysfunction is one contributing factor, but its role at different stages of disease progression is not fully understood. Here, we showed that neural precursor cells and dopaminergic neurons derived from induced pluripotent stem cells (hiPSCs) from sPD patients exhibited a hypometabolism. Further analysis based on transcriptomics, proteomics, and metabolomics identified the citric acid cycle, specifically the α-ketoglutarate dehydrogenase complex (OGDHC), as bottleneck in sPD metabolism. A follow-up study of the patients approximately 10 years after initial biopsy demonstrated a correlation between OGDHC activity in our cellular model and the disease progression. In addition, the alterations in cellular metabolism observed in our cellular model were restored by interfering with the enhanced SHH signal transduction in sPD. Thus, inhibiting overactive SHH signaling may have potential as neuroprotective therapy during early stages of sPD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Complex-i Deficiency; Ketoglutarate Dehydrogenase; Computational Platform; Comprehensive Analysis; Sonic Hedgehog; Acid Cycle; Brain; Mitochondria; Glucose; Enzyme
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
0
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 14,
Heft: 1,
Seiten: ,
Artikelnummer: 7674
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30204 - Cell Programming and Repair
30201 - Metabolic Health
30205 - Bioengineering and Digital Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-500500-001
G-505600-003
G-503800-001
G-509300-001
G-500600-001
G-506900-001
Förderungen
Helmholtz Association through the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Helmholtz Association through the Niedersaechsisches Vorab
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) through ACS_iIMMUNE
ForInter consortium
Bavarian Ministry of Science and the Arts in the framework of the ForIPS consortium
Copyright
Erfassungsdatum
2023-12-11